7 Oct 2022

October is National Mental Health Month: Week 2

Mental Health Awareness Month Week 2

Around 1 in 5 Australian adults experience a common mental illness each year. Understanding how to talk about mental health and help someone in need are important skills.

This year’s National Mental Health Awareness Campaign theme is: ‘Building Resilience: Communities and Connections’

October is National Mental Health Month: Week 1

Welcome to October!

October is National Mental Health Month, an initiative of the Mental Health Foundation Australia, to advocate for and raise awareness of mental health. This year’s National Mental Health Awareness Campaign theme is: ‘Building Resilience: Communities and Connections’

Throughout October, the CCS GEDI committee will be sharing resources weekly to encourage all staff and students to reflect on their own mental health, as well as the mental health of their family, friends and colleagues throughout the CCS.

Congratulations on Vanguard grant for precision heart imaging

Ex vivo scans of hearts from fibrotic (left) and control mice which
were administered a unique fluorescent peptide that targets collagen
type I. A striking enhancement of the damaged heart ventricles
is observed. Image: Figure 5 in study

Dr Be'eri Niego (CIA), Dr Karen Alt (CIB) and Professor Christoph Hagemeyer (CIC) are recipients of a Heart Foundation Vanguard grant announced 6 October. The grant is for $150,000 across two years.

Dr Alt said, "In this project, we aim to develop new peptides, which tightly bind various types of collagen and enable the delivery of imaging contrast agents to the affected heart. This clever approach, also termed 'Molecular Imaging', allows more sensitive imaging and earlier diagnosis of heart conditions."

See all 2022 Vanguard grant recipients at the A+ precinct here.

6 Oct 2022

Reducing the high rate of chronic kidney disease in First Nations communities

Why are First Nations people more vulnerable to developing CKD?
An MRFF funded study is finding out. Image: Shutterstock

Indigenous-led research is using advanced multi-omics technology to reduce the high rate of chronic kidney disease in First Nations communities.

In 2020 a team of Monash, Baker and SAHMRI researchers received MRFF funding of $2M to investigate chronic kidney disease (CKD) in Indigenous populations for their project entitled "Reducing the burden of chronic kidney disease in the Indigenous population - the PROPHECY CKD study" to investigate why First Nations Peoples have one of the highest rates of chronic kidney disease (CKD) in the world. 

Two years on, they know more as they follow up on close to 1500 First Nations donors of blood samples.

See faculty story.

Participants sought for a survey on human monkeypox

What do people know and think about monkeypox?

We would love to hear from you (check eligibility below first!) We are running a survey to find out what people know and believe about human monkeypox. We also invite you to share with eligible people.

Monash University and Melbourne Sexual Health Centre are running an online anonymous survey to understand the current knowledge of monkeypox and the willingness to get vaccinated.

You are eligible if you:

  • identify yourself as a man or trans woman who has sex with men; AND
  • are currently living in Victoria, Australia; AND
  • are 18 years old or above.

5 Oct 2022

Fixing Australia’s home-based aged care system

Lens article featuring Professor Velandai Srikanth, Peninsula Clinical School, Director, National Centre for Healthy Ageing

We know the system of home-based aged care isn’t working well – it lacks integration, is mostly labour-driven and susceptible to workforce challenges, and uses limited technology that could benefit older people and the staff working to help them.

See full article on the Lens site.

3 Oct 2022

B cell boost for hay fever therapy

L-R: Authors Dr Craig McKenzie, Prof Robyn O'Hehir and
Prof Menno van Zelm. See paper for full list of authors.
Grass pollen allergy is the leading cause of seasonal asthma and hay fever globally with up to 30 per cent of the world’s population allergic to grass pollen allergens.

In a discovery that may help scientists alleviate this global burden, Monash researchers have found that sublingual immunotherapy (SLIT) with a small tablet containing grass pollens, changed patient’s immune memory cells in unexpected ways.

See full faculty story.

Related Posts Plugin for WordPress, Blogger...